Back to companies
Indivior Pharmaceuticals, Inc.
INDVUSNASDAQPharmaceuticals & HealthcareIndivior Pharmaceuticals, Inc.
Revenue
$1.2bn
YoY +4.3%
Operating income
$262.0mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API